ACHE and early-onset autosomal dominant Alzheimer disease: AChE is a well-known serine hydrolase that catalyzes the hydrolysis of the neurotransmitter acetylcholine into choline and acetic acid [37]; inhibiting it would increase acetylcholine levels in the brain, enhancing cholinergic synapses in Alzheimer’s disease patients [38,39].